Skip to main content
ACB logo

Aurora Cannabis Inc. (ACB) Stock Price & Analysis

Aurora Cannabis Inc. (ACB) — MoonshotScore 19/100 (Weak band), calculated Nov 22, 2026. Price $4.16 (-2.35%), as of the Nov 20, 2026 trading session; market cap $274M.

Educational signal · not a buy or sell recommendation · How to read this

$4.16 −$0.10 (-2.35%) Market Cap $274M

Aurora Cannabis Inc. · ACB · NASDAQ

Aurora Cannabis Inc. produces and distributes cannabis and cannabis derivative products in Canada and internationally. The company is involved in facility engineering, cannabis breeding, research, and product development within the cannabis industry.

Price as of Nov 20, 2026

Key Statistics

19 of 100

MoonshotScore v2 · Aurora Cannabis (ACB)

Weak
Business Quality Average (54)
Financial Safety Strained (34)
Valuation Fair (67)
Growth Durability Shrinking (16)
Momentum Surging (82)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Strong price action running well ahead of the business — stalling growth underneath; a move to treat with suspicion, not chase. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Average; Financial Safety: Strained; Valuation: Fair; Growth Durability: Shrinking; Momentum: Surging.

  • quarterly revenue C$86M (Q2 FY2027, quarter ended Sep 2026)
  • EPS beat 2 of the last 8 reports
  • Altman Z -11.08 · Piotroski F 4

Holding back: balance-sheet strain, soft growth

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ACB (53 recorded, newest six shown)
RecordedScoreBand
18Weak
19Weak
19Weak
19Weak
19Weak
19Weak

The score was 19 in the stored Nov 21, 2026 snapshot and remains 19 in the current publication computed Nov 22, 2026 (0); the largest pillar moves were Momentum -3 and Valuation +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$4.16
Change on the day-2.35%
52-week range$2.56 – $6.36
Market capitalisation$274M
Shares traded on the day900.0K

Price & events

Other perspectives

Council score for Aurora Cannabis (ACB): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Weak
Valuation Moderate
Growth Durability Negative
Momentum Strong

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 22, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Strong
ROE Negative
Gross Margin Moderate

Read on: Nov 22, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Two of these lenses read this company more favourably than the MoonshotScore does: Dalio-style lens and Moon AI lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 22, 2026, except a card that shows its own read date.

1 · What is it?

What is Aurora Cannabis (ACB), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Aurora Cannabis Inc. (ACB) is listed on NASDAQ. It employs 1,028 people and is led by Miguel Martin. In Q2 FY2027 it reported revenue of C$86M and net income of -C$21M. The market values it at $274M.

2 · Latest results

What do the latest results show for Aurora Cannabis (ACB)?

Short answer · as of

The most recent reported quarter, Q2 FY2027, carried revenue of C$86M. Against analyst estimates the company has EPS beat 2 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2027C$86M-C$21M-C$0.32 (diluted)
Q1 FY2027C$68M-C$4M-C$0.07 (diluted)
Q4 FY2026C$38M-C$57M-C$0.99 (diluted)
Q3 FY2026C$94MC$2MC$0.03 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Aurora Cannabis (ACB)?

Short answer

The MoonshotScore pillars rate positive momentum as strengths. What is holding it back is balance-sheet strain, soft growth. The distress and quality screens read Altman Z -11.08 · Piotroski F 4. Trailing ratios: ROE -15.3% · ROA -13.1% · current ratio 5.00 · earnings yield -20.7% · free-cash-flow yield -6.5%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -11.08 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-15.3%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
5 · Peer comparison

How does Aurora Cannabis compare with its peers?

Short answer

Aurora Cannabis's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Kamada Ltd. (KMDA) Same industry, near in market value$7.74 Nov 20, 2026$446M87 5-pillar Nov 22, 2026
Embecta Corp. (EMBC) Same industry, near in market value$6.02 Nov 20, 2026$341M71 5-pillar Nov 22, 2026
Collegium Pharmaceutical, Inc. (COLL) Same industry, near in market value$24.72 Nov 20, 2026$768M58 5-pillar Nov 22, 2026
Cardiol Therapeutics Inc. (CRDL) Same industry, near in market value$0.86 Nov 20, 2026$110M49 5-pillar Nov 22, 2026
SIGA Technologies, Inc. (SIGA) Same industry, near in market value$2.40 Nov 20, 2026$172M39 5-pillar Nov 22, 2026
Ironwood Pharmaceuticals, Inc. (IRWD) Same industry, near in market value$4.70 Nov 20, 2026$778M39 5-pillar Nov 22, 2026
Alpha Teknova, Inc. (TKNO) Same industry, near in market value$7.63 Nov 20, 2026$480M34 5-pillar Nov 22, 2026
SNDL Inc. (SNDL) Same industry, near in market value$1.17 Nov 20, 2026$285M31 5-pillar Nov 22, 2026
Organogenesis Holdings Inc. (ORGO) Same industry, near in market value$0.77 Nov 20, 2026$100M28 5-pillar Nov 22, 2026
Emergent BioSolutions Inc. (EBS) Same industry, near in market value$5.05 Nov 20, 2026$260M24 5-pillar Nov 22, 2026
Evolus, Inc. (EOLS) Same industry, near in market value$6.52 Nov 20, 2026$432M22 5-pillar Nov 22, 2026
Lifecore Biomedical, Inc. (LFCR) Same industry, near in market value$6.39 Nov 20, 2026$242M21 5-pillar Nov 22, 2026
Aurora Cannabis (ACB) — this page$4.16$274M19

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ACB in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ACB in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Aurora Cannabis (ACB)?

Read these with our analysis →

Investor Questions: ACB Stock

These answers are editorial: 1 of these 9 answers is drawn from the ACB research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ACB?

ACB carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Aurora Cannabis Inc. produces and distributes cannabis and cannabis derivative products in Canada and internationally.

Is ACB a good stock to buy?

Stock Expert AI does not rate ACB buy, sell or hold. Aurora Cannabis Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ACB stock price today?

The last price recorded for Aurora Cannabis Inc. (ACB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about ACB stock?

Analyst consensus on Aurora Cannabis Inc. (ACB) stock is mixed, reflecting the uncertainties and challenges in the cannabis industry. Key valuation metrics, such as price-to-sales and price-to-book ratios, are often considered in relation to the company's growth potential and profitability prospects.

What are the key factors to evaluate for ACB?

Aurora Cannabis Inc. (ACB) holds a MoonshotScore in the low range. Aurora Cannabis Inc. does not currently offer a dividend, which is common among growth-oriented companies in the cannabis sector. Not financial advice.

How frequently does ACB data refresh on this page?

ACB's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ACB's recent stock price performance?

Aurora Cannabis Inc. (ACB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio catering to both medical and recreational markets. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ACB overvalued or undervalued right now?

Aurora Cannabis Inc. (ACB) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of ACB?

Fractional-share availability for Aurora Cannabis Inc. (ACB) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 16 figures on this page — 8 from Financial Modeling Prep (FMP), 6 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.